Arenobufagin suppresses the progression of early-stage hepatocellular carcinoma by inhibiting EpCAM-mediated tumor stemness
Epithelial cell adhesion molecule (EpCAM) is a biomarker for epithelial cell-derived tumors. However, the specific role of EpCAM itself in early-stage hepatocellular carcinoma progression remains unclear, and small molecules targeting EpCAM have not yet been reported. Here, the protein expression pr...
Saved in:
| Main Authors: | Lijuan Deng, Lifang Zou, Chunhong Zhou, Fuqin Yang, Fen Ouyang, Yingru Zhu, Huihui Cao, Min Hu, Xiaoshen Zhang, Junshan Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Compuscript Ltd
2025-01-01
|
| Series: | Acta Materia Medica |
| Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2024-0064 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Silico Design of Novel EpCAM-Binding Aptamers for Targeted Delivery of RNA Therapeutics
by: Julia Driscoll, et al.
Published: (2024-10-01) -
High-Affinity Fully Human Anti-EpCAM Antibody with Biased IL-2 Exhibits Potent Antitumor Activity
by: Zhi Wang, et al.
Published: (2024-11-01) -
In vivo dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer
by: Tao Xu, et al.
Published: (2023-12-01) -
EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1
by: Pil Soo Sung, et al.
Published: (2020-05-01) -
A novel conditional active biologic anti-EpCAM x anti-CD3 bispecific antibody with synergistic tumor selectivity for cancer immunotherapy
by: Gerhard Frey, et al.
Published: (2024-12-01)